Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2
Work
Year: 2022
Type: article
Abstract: New antimalarial treatments with novel mechanism of action are needed to tackle Plasmodium falciparum infections that are resistant to first-line therapeutics. Here we report the exploration of MMV692... more
Source: ChemMedChem
Institutions Medicines for Malaria Venture, Columbia University Irving Medical Center, Washington University in St. Louis, University of Dundee, GlaxoSmithKline (Spain) +7 more
Cites: 17
Cited by: 7
Related to: 10
FWCI: 1.995
Citation percentile (by year/subfield): 86.07
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $3,760
Funder World Health Organization